Key Points
- Billiontoone CTO David Tsao sold 10,000 shares at an average price of $92.86, generating $928,600. The Rule 10b5-1 transaction reduced his ownership by 90.91%, leaving him with 1,000 shares.
- Billiontoone recently reported quarterly revenue of $109.45 million and EPS of $0.15, matching analyst estimates. The stock opened at $97.45, with a market capitalization of approximately $4.48 billion.
- Analysts maintain a generally positive outlook, with six Buy, three Hold, and one Sell rating; the consensus rating is “Moderate Buy” with a $126.71 price target, although JPMorgan and BTIG recently lowered their targets to $130.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 1,417 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $92.86, for a total value of $131,582.62. Following the completion of the transaction, the senior vice president owned 27,884 shares of the company's stock, valued at $2,589,308.24. This trade represents a 4.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total value of $169,920.00.
- On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The stock was sold at an average price of $101.47, for a total value of $287,363.04.
Billiontoone Stock Performance
Shares of BLLN opened at $97.45 on Thursday. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The company has a 50-day moving average of $116.70 and a two-hundred day moving average of $94.55. The stock has a market cap of $4.48 billion and a price-to-earnings ratio of 139.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.
Billiontoone (NASDAQ:BLLN - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, equities research analysts expect that Billiontoone, Inc. will post 0.83 earnings per share for the current year.
Hedge Funds Weigh In On Billiontoone
Several hedge funds have recently bought and sold shares of the business. Rossby Financial LCC acquired a new stake in shares of Billiontoone in the fourth quarter worth about $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone during the 4th quarter valued at about $76,000. Smartleaf Asset Management LLC acquired a new position in shares of Billiontoone during the 4th quarter valued at about $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Billiontoone in the 4th quarter valued at approximately $82,000. Finally, Renaissance Capital LLC bought a new position in shares of Billiontoone in the 4th quarter valued at approximately $201,000.
Analysts Set New Price Targets
Several brokerages have recently commented on BLLN. Wall Street Zen cut Billiontoone from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Guggenheim initiated coverage on Billiontoone in a research report on Monday, June 29th. They set a "buy" rating and a $125.00 price target on the stock. JPMorgan Chase & Co. reduced their price objective on Billiontoone from $145.00 to $130.00 and set an "overweight" rating for the company in a research note on Thursday, August 6th. Weiss Ratings raised Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research note on Tuesday, June 23rd. Finally, BTIG Research reduced their price target on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a research report on Thursday, August 6th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $126.71.
View Our Latest Analysis on Billiontoone
About Billiontoone
(
Get Free Report)
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
